Latest Period
Q2 2026
Security Snapshot
Aimei Health Technology Co., Ltd. - Ordinary Shares, par value $0.0001 per share (AFJK) Institutional Ownership
CUSIP: G01341109
13F Institutional Holders and Ownership History from Q1 2024 to Q2 2026
Institutions Reporting
7
Shares (Excl. Options)
974,420
Price
$11.52
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, par value $0.0001 per share
- Symbol
- AFJK on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 974,420
- Total 13F value
- $11,095,107
- Portfolio coverage rank
- 0%
- Share change
- -28
- Value change
- +$225
- Number of holders
- 7
- Shares outstanding
- 3,165,736
- SEC-reported price per share
- $12.02
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AFJK - Aimei Health Technology Co., Ltd. - Ordinary Shares, par value $0.0001 per share is tracked under CUSIP G01341109.
- 7 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 6 to 7 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $11,093,498 to $11,095,107.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 7 institutions filings for Q2 2026.
Security key
G01341109
Latest holder period
Q2 2026
13F holders
7
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
AFJK full holder history
Aimei Health Technology Co., Ltd. SEC filings
Aimei Health Technology Co., Ltd. company facts
Aimei Health Technology Co., Ltd. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G01341109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
AFJK
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| First Trust Capital Management L.P. | 21% | +94% | $8,309,600 | 680,000 | 0% | First Trust Capital Management L.P. | 30 Apr 2026 | |
| GLAZER CAPITAL, LLC | 6.7% | $6,663,745 | 605,795 | Glazer Capital, LLC | 31 Dec 2024 | |||
| Karpus Management, Inc. | 1.3% | -91% | $2,798,989 | -$35,910,120 | 78,075 | -93% | KARPUS MANAGEMENT, INC. | 31 Dec 2025 |
As of 30 Jun 2026, 7 institutional investors reported holding 974,420 shares of Aimei Health Technology Co., Ltd. - Ordinary Shares, par value $0.0001 per share (AFJK). This represents 31% of the company’s total 3,165,736 outstanding shares.
13F concentration
Top 8 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
31%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| First Trust Capital Management L.P. | 21% | 680,000 | 0% | 0.45% | $7,731,600 |
| GLAZER CAPITAL, LLC | 4.2% | 133,744 | 0% | 0.04% | $1,521,000 |
| Clear Street Group Inc. | 2.6% | 83,337 | 0% | 0% | $947,542 |
| Karpus Management, Inc. | 2.4% | 77,125 | 0% | 0.03% | $888,480 |
| SBI Securities Co., Ltd. | 0% | 112 | 0% | $3,394 | |
| UBS Group AG | 0% | 59 | +321% | 0% | $1,788 |
| MORGAN STANLEY | 0% | 43 | 0% | 0% | $1,303 |
| Federation des caisses Desjardins du Quebec | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q2 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 974,420 | $11,095,107 | +$225 | $11.52 | 7 |
| 2026 Q1 | 974,405 | $11,093,498 | -$1,150,244 | $11.45 | 6 |
| 2025 Q4 | 19,751 | $1,264,258 | -$20,689,756 | $64.01 | 7 |
| 2025 Q3 | 3,847,815 | $43,435,993 | -$839,152 | $11.32 | 17 |
| 2025 Q2 | 3,900,428 | $43,214,842 | -$442,173 | $11.07 | 16 |
| 2025 Q1 | 3,941,452 | $43,325,723 | -$25,295,273 | $11.00 | 16 |
| 2024 Q4 | 6,300,299 | $66,966,106 | -$4,771,373 | $10.70 | 23 |
| 2024 Q3 | 6,806,994 | $71,329,083 | +$1,170,036 | $10.48 | 31 |
| 2024 Q2 | 6,529,401 | $67,561,399 | +$657,851 | $10.35 | 30 |
| 2024 Q1 | 6,469,886 | $66,184,452 | +$63,118,452 | $10.22 | 26 |